Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Sep 1;132(9):796-803.
doi: 10.1161/CIRCULATIONAHA.114.013243. Epub 2015 Jul 29.

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

Affiliations
Randomized Controlled Trial

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

Wobo Bekwelem et al. Circulation. .

Abstract

Background: Nonvalvular atrial fibrillation is a major cause of thromboembolic events. In comparison with atrial fibrillation-related stroke, extracranial systemic embolic events (SEEs) remain poorly defined.

Methods and results: All suspected SEEs reported among 37 973 participants of 4 large contemporary randomized clinical trials of anticoagulation in atrial fibrillation were independently readjudicated for clinical and objective evidence of sudden loss of perfusion of a limb or organ. Over 91 746 patient-years of follow-up, 221 SEEs occurred in 219 subjects. The SEE incidence was 0.24 of 100 and stroke incidence was 1.92 of 100 patient-years. In comparison with patients with stroke, those with SEE were more often female (56% versus 47%; P=0.01) and had comparable mean age (73.1±8.5 versus 73.5±8.8 years; P=0.57) and mean CHADS2 scores (2.4±1.3 versus 2.5±1.2; P=0.33). SEEs more frequently involved the lower extremity (58%) than visceral-mesenteric (31%) or upper extremity (10%). SEE-related care involved clinic assessment alone in 5%, 30% were hospitalized without procedures, 60% underwent endovascular or surgical intervention, and 5% underwent amputation. Within 30 days, 54% of patients recovered fully, 20% survived with deficits, and 25% died. Thirty-day mortality was greater after visceral-mesenteric than lower- or upper-extremity SEE (55%, 17%, and 9%, respectively, P≤0.0001). The relative risk of death throughout follow-up was 4.33 (95% confidence interval, 3.29-5.70) after SEE versus 6.79 (95% confidence interval, 6.22-7.41) after stroke in comparison with patients without either event.

Conclusions: SEE constituted 11.5% of clinically recognized thromboembolic events in patients with atrial fibrillation and was associated with high morbidity and mortality. SEE mortality was comparable to that of ischemic stroke and varied by anatomic site.

Keywords: arrhythmias, cardiac; atrial fibrillation; embolism; peripheral artery disease; risk factors.

PubMed Disclaimer

Comment in

Similar articles

Cited by

  • Coronary Artery Embolism and Myocardial Infarction, case report.
    Narváez Orozco A, Navarro Navajas A, Cardona Buitrago C, Senior-Sánchez JM, Ortiz Uribe JC, Delgado Restrepo JA. Narváez Orozco A, et al. Arch Peru Cardiol Cir Cardiovasc. 2024 Mar 19;5(1):45-49. doi: 10.47487/apcyccv.v5i1.347. eCollection 2024 Jan-Mar. Arch Peru Cardiol Cir Cardiovasc. 2024. PMID: 38596603 Free PMC article.
  • Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
    Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Benjamin EJ, et al. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Circulation. 2017. PMID: 28122885 Free PMC article. Review. No abstract available.
  • Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
    Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Tsao CW, et al. Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25. Circulation. 2023. PMID: 36695182 Free PMC article. Review.
  • Reversible thrombocytopenia during hibernation originates from storage and release of platelets in liver sinusoids.
    de Vrij EL, Bouma HR, Goris M, Weerman U, de Groot AP, Kuipers J, Giepmans BNG, Henning RH. de Vrij EL, et al. J Comp Physiol B. 2021 May;191(3):603-615. doi: 10.1007/s00360-021-01351-3. Epub 2021 Mar 4. J Comp Physiol B. 2021. PMID: 33661336 Free PMC article.
  • Effect of China national centralized drug procurement policy on anticoagulation selection and hemorrhage events in patients with AF in Suining.
    Zhang Q, Wang R, Chen L, Chen W. Zhang Q, et al. Front Pharmacol. 2024 Feb 20;15:1365142. doi: 10.3389/fphar.2024.1365142. eCollection 2024. Front Pharmacol. 2024. PMID: 38444941 Free PMC article.

Publication types

LinkOut - more resources